Selectively inhibit SRC/ABL kinases, such as ABL, SRC, LCK, and YES with Dasatinib (Lombardo et al. J Med Chem, 2004; Davis et al. Nat Biotechnol, 2011). This tyrosine kinase inhibitor inhibits proliferation in cell lines derived from chronic myeloid leukemia (CML), prostate, breast, and colon tumors (Lombardo et al. J Med Chem, 2004; Davis et al. Nat Biotechnol, 2011); induces cell-cycle arrest and apoptosis and decreasing growth in thyroid cancer cells (Chan et al. Clin Cancer Res, 2012); and inhibits the production of extracellular matrix proteins in dermal fibroblasts and prevents the development of bleomycin-challenge-induced fibrosis in mice (Distler & Distler. Rheumatology, 2008; Akhmetshina et al. FASEB J, 2008). Dasatinib is supplied as a crystalline solid with ≥98% purity; Molecular weight 488.0 g/mol; CAS Number 302962-49-8. Visit STEMCELL.com for more information and related products.